Markers of Eosinophilic Inflammation and Tissue Re-modelling in Children Before Clinically Diagnosed Bronchial Asthma
Overview
Affiliations
Chronic inflammatory changes in the bronchial mucosa have been well documented in patients with established asthma. Much less is known of the changes, which occur in the airways of children early in the evolution of their disease with most of the information based on indirect markers of inflammation only. We evaluated markers of inflammation and tissue re-modelling in bronchial biopsies from children with early respiratory symptoms before a clear clinical diagnosis of bronchial asthma could be made. We examined bronchial biopsies performed in 27 children between the ages of 1.2 and 11.7 yr who were bronchoscoped for a clinical indication because of recurrent or chronic respiratory symptoms. The patients were re-evaluated 22-80 months after the original bronchoscopy to determine whether or not they had subsequently developed bronchial asthma. There were more eosinophils in the bronchial mucosa (129.4 vs. 19.1 cells/mm2 of lamina propria, p <0.001) and the thickness of the subepithelial lamina reticularis was greater (4.65 vs. 3.72 microm, p=0.044) in children with bronchial asthma diagnosed at follow-up, compared with the children who did not progress to asthma. Eosinophilic inflammation and airway re-modelling occur early in the natural history of bronchial asthma and are present even before asthma would be diagnosed based on clinical symptoms. Recognition of these changes and their significance for clinical disease should emphasize the need for timely detection and diagnosis of asthma in children to facilitate the early introduction of anti-asthma therapy.
Childhood lung function is associated with adolescent-onset and persistent asthma.
Koefoed H, Ullah A, Hallberg J, Merid S, Kere M, Lowe L ERJ Open Res. 2024; 10(6).
PMID: 39655169 PMC: 11626625. DOI: 10.1183/23120541.00469-2024.
Oxidative Stress and Antioxidants in Pediatric Asthma's Evolution and Management.
Ioniuc I, Lupu A, Dragan F, Tarnita I, Alexoae M, Streanga V Antioxidants (Basel). 2024; 13(11).
PMID: 39594473 PMC: 11590961. DOI: 10.3390/antiox13111331.
Biologics and airway remodeling in asthma: early, late, and potential preventive effects.
Varricchi G, Poto R, Lommatzsch M, Brusselle G, Braido F, Virchow J Allergy. 2024; 80(2):408-422.
PMID: 39520155 PMC: 11804314. DOI: 10.1111/all.16382.
Airway remodelling in asthma and the epithelium: on the edge of a new era.
Varricchi G, Brightling C, Grainge C, Lambrecht B, Chanez P Eur Respir J. 2024; 63(4).
PMID: 38609094 PMC: 11024394. DOI: 10.1183/13993003.01619-2023.
The epithelium takes the stage in asthma and inflammatory bowel diseases.
Lopez-Posadas R, Bagley D, Pardo-Pastor C, Ortiz-Zapater E Front Cell Dev Biol. 2024; 12:1258859.
PMID: 38529406 PMC: 10961468. DOI: 10.3389/fcell.2024.1258859.